Trial intelligence / Profile preview

Dexmedetomidine vs Midazolam for Intraoperative Sedation

NCT02878837Phase 4Completed

Sponsor
IAMSPE
Start
Jan 2016
Primary completion
Apr 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of dexmedetomidine in Procedural sedation (PS) (2 arms), sponsored by IAMSPE. Primary endpoints: Depth of Sedation, Respiratory depression and 2 more. Started Jan 2016; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

Procedural sedation (PS)

Beyond the preview

Go deeper on NCT02878837.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02878837.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call